Drug-Eluting Stents Market Set to Surpass USD 14.2 Bn by 2035, Driven by Technological Advancements and Rising Cardiovascular Burden | TMR

The global Drug-Eluting Stents (DES) Market is poised for substantial expansion, projected to grow from US$ 7.7 Bn in 2024 to over US$ 14.2 Bn by 2035, reflecting a steady CAGR of 5.7% during the forecast period (2025-2035). This growth is primarily propelled by ongoing technological advancements, increasing cardiovascular disease incidence, and rising preference for minimally invasive interventions worldwide.

Unlock crucial data and key findings from our Report in this sample -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=30632

Drug-eluting stents-advanced medical devices coated with therapeutics such as Sirolimus, Paclitaxel, Zotarolimus, and Everolimus-have transformed coronary artery disease (CAD) treatment. By preventing scar tissue growth and restenosis, DES have demonstrated superior clinical outcomes compared to bare-metal stents.

Strong Market Drivers Fueling Growth
The market is witnessing robust momentum due to:

Introduction of advanced DES technologies: Innovations in stent design, polymer science, and drug delivery systems have dramatically improved biocompatibility and long-term performance.

Rising global burden of cardiovascular diseases (CVDs): Aging populations, sedentary lifestyles, and increasing rates of diabetes and hypertension are accelerating demand for DES-based treatments.

Growing preference for minimally invasive cardiology: DES reduce repeat procedures, shorten recovery time, and offer enhanced patient outcomes.

Supportive reimbursement and government healthcare initiatives: Especially across developed regions, these programs continue to encourage the adoption of next-generation stents.

However, high treatment costs and risks associated with complications such as restenosis and thrombosis continue to pose challenges. Ongoing R&D in biodegradable polymers and advanced drug combinations is expected to mitigate these concerns.

Polymer-Based DES Lead the Market
Polymer material-based DES dominate the global market owing to their controlled drug-release capabilities, superior biocompatibility, and flexibility in navigating complex vascular structures. Emerging biodegradable polymer platforms are further strengthening market appeal by reducing long-term complications and decreasing reliance on prolonged antiplatelet therapy.

Consult our report for a thorough exploration of essential insights -

https://www.transparencymarketresearch.com/drug-eluting-stents-market.html

North America Remains the Leading Regional Market
North America held the largest market share in 2024, supported by:

High prevalence of cardiovascular diseases

Well-established healthcare infrastructure

Strong R&D investments by leading medical device manufacturers

Favorable regulatory frameworks ensuring product safety and efficacy

The region's advanced clinical adoption of minimally invasive procedures continues to position it as a global leader in DES implementation.

Key Industry Developments
Recent product advancements are reshaping the competitive landscape:

June 2024: Elixir Medical received FDA Breakthrough Device Designation for its DynamX Sirolimus-Eluting Coronary Bioadaptor System targeting improved lumen diameter and reduced plaque progression.

May 2024: Abbott launched its XIENCE Sierra Everolimus-Eluting Coronary Stent System in India-one of the latest innovations in the XIENCE stent family.

Leading Market Participants
Key companies operating in the global DES market include:

Abbott Laboratories, AlviMedica, B. Braun Melsungen AG, Biosensors International Group, Ltd., Shandong JW Medical Systems LTD., Boston Scientific Corporation, Cook Medical Inc., Elixir Medical Corp., Lepu Medical Technology (Beijing) Co., Ltd., Medtronic plc, Eurocor GmbH, OrbusNeich Medical Company Limited, Shanghai MicroPort Medical Co., Ltd., and Sino Medical Sciences Technology Inc.

These companies continue to enhance their product portfolios through technology integration, material innovation, and strategic regional expansions.

Buy this Premium Research Report and access vital insights and analysis -

https://www.transparencymarketresearch.com/checkout.php?rep_id=30632<ype=S

Market Outlook
The Drug-Eluting Stents Market is set for consistent growth, supported by technological breakthroughs, demographic shifts, and the global fight against cardiovascular diseases. As patient-focused stent solutions evolve with next-generation materials and drug delivery mechanisms, DES remain central to modern interventional cardiology.

Explore Latest Research Reports by Transparency Market Research:

Remote Patient Monitoring Devices Market - https://www.transparencymarketresearch.com/remote-patient-monitoring-devices-market.html

Wound Healing Market - https://www.transparencymarketresearch.com/wound-healing-market.html

Contraceptive Sponge Market - https://www.transparencymarketresearch.com/contraceptive-sponge-market.html

Vaginal Pessaries Market - https://www.transparencymarketresearch.com/vaginal-pessaries-market-report.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.